Cefuroxime
Back to searchMolecule Structure
Scientific Name
Cefuroxime
Description of the Drug
Cefuroxime is a cephalosporin indicated for the treatment of a variety of infections including acute bacterial otitis media, several upper respiratory tract infections, skin infections, urinary tract infections, gonorrhea, early Lyme disease, and impetigo.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01112
http://www.drugbank.ca/drugs/DB01112
Brand Name(s)
Not Available
Company Owner(s)
Samson Medical Technologies Llc, Fresenius Kabi Usa Llc, Hospira Inc, Watson Laboratories Inc, Eli Lilly And Co, Pai Holdings Llc Dba Pharmaceutical Associates Inc, Hikma Farmaceutica Portugal Lda, B Braun Medical Inc, Teva Pharmaceuticals Usa, Acs Dobfar Spa
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1821942 | ||
Human Metabolome Database | HMDB0015244 | ||
DrugBank | DB01112 | ||
PubChem: Thomson Pharma | 14758434 | 16838488 | |
PubChem | 5479529 | ||
NMRShiftDB | 60027800 | ||
LINCS | LSM-44947 | ||
Nikkaji | J13.093A | ||
PDBe | KOV | ||
BindingDB | 50422689 | ||
DrugCentral | 565 | ||
ChemicalBook | CB7707485 | ||
Guide to Pharmacology | 10900 | ||
rxnorm | CEFUROXIME | ZINACEF | CEFUROXIME SODIUM |
PubChem: Drugs of the Future | 12015285 | ||
KEGG Ligand | C06894 | ||
ChEBI | 3515 | ||
ZINC | ZINC000003871978 |